Inhibiting the vascular smooth muscle cells proliferation by EPC and DPPC liposomes encapsulated Magnolol

Journal of the Chinese Institute of Chemical Engineers

Volumn 39, Issue 5, 2008, Pages 407-411

  Chen, Calvin Yu Chian ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

1,2 Diacyl Sn glycero 3 phosphocholine Magnolol; 1,2 Dipalmitoyl Sn glycero 3 phosphocholine; Liposome; Vascular smooth muscle cells

Indexed keywords

CELLS; DISEASES; EFFICIENCY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LIPID BILAYERS; LIPOSOMES; MUSCLE; PARTICLE SIZE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET VISIBLE SPECTROSCOPY;

1 ,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE-MAGNOLOL; 1 ,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHOCHOLINE; ENCAPSULATION EFFICIENCY; INHIBITING EFFICIENCIES; PARTICLES SIZES; PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY; UV-VIS SPECTROSCOPY; VASCULAR SMOOTH MUSCLE CELLS;

ENCAPSULATION;

EID: 56949087889     PISSN: 03681653     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcice.2008.04.005     Document Type: Article

References (21)

1. Allen, T. M., W. W. Cheng, J. I. Hare, and K. M. Laginha, "Pharmacokinetics and Pharmacodynamics of Lipidic Nano-Particles in Cancer," Anticancer Agents Med. Chem., 6 (6), 513 (2006).
2. Chen, J. H., C. C. Wu, G. Hsiao, and M. H. Yen, "Magnolol Induces Apoptosis in Vascular Smooth Muscle," Naunyn Schmiedebergs Arch. Pharmacol., 368 (2), 127 (2003).
3. Chew, D. P, "Cost-Effectiveness of Drug-Eluting Stents: If Only All Things Were Equal. They Reduce Rates of Restenosis but Not Mortality or Infarction - So Are They Worth It?" Med. J. Aust., 182 (8), 376 (2005).
4. Currier, J. W. and D. P. Faxon, "Restenosis After Percutaneous Transluminal Coronary Angioplasty: Have We Been Aiming at the Wrong Target?" J. Am. Coll. Cardiol., 25 (2), 516 (1995).
5. Farb, A., G. Sangiorgi, A. J. Carter, V M. Walley, W. D. Edwards, R. S. Schwartz, and R. Virmani, "Pathology of Acute and Chronic Coronary Stenting in Humans," Circulation, 99 (1), 44 (1999).
6. Hong, C. Y., S. S. Huang, and S. K. Tsai, "Magnolol Reduces Infarct Size and Suppresses Ventricular Arrhythmia in Rats Subjected to Coronary Ligation," Clin. Exp. Pharmacol. Physiol., 23 (8), 660 (1996).
7. Kuntz, R. E. and D. S. Baim, "Defining Coronary Restenosis: Newer Clinical and Angiographic Paradigms," Circulation, 88 (3), 1310 (1993).
8. Kuo, Y C. and C. Y Chung, "Transport of Zidovudine- and Lamivudine-Loaded Polybutylcyanoacrylate and Methylmethacrylate-Sulfopropyl-methacrylate Nanoparticles across the in vitro Blood-Brain Barrier: Characteristics of the Drug-Delivery System," J. Chin. Inst. Chem. Engrs., 36 (6), 627 (2005).
9. Lafont, A., L. A. Guzman, P. L. Whitlow, M. Goormastic, J. F. Cornhill, and G. M. Chisolm, "Restenosis after Experimental Angioplasty: Intimal, Medial, and Adventitial Changes Associated with Constrictive Remodeling," Circ. Res., 76 (6), 996 (1995).
10. Lee, Y. M., G. Hsiao, H. R. Chen, Y C. Chen, J. R. Shen, and M. H. Yen, "Magnolol Reduces Myocardial Ischemia/Reperfusion Injury via Neutrophil Inhibition in Rats," Eur. J. Pharmacol., 422 (1-3), 159 (2001).
11. Lin, Y. M., D. Z. Liu, H. M. Haw, and L. P. Tseng, "Measurement of the Second Virial Coefficient of DPPC- and DPPG-Liposomes by Isothermal Titration Calorimetry," J. Chin. Inst. Chem. Engrs., 38 (2), 103 (2007).
12. Liu, D. Z., W. Y. Chen, L. M. Tsai, and S. P. Yang, "Phase-Transfer Catalytic Reaction of Ethyl-2-bromoisobutyrate and Phenol: Effects of Water and Temperature," J. Chin. Inst. Chem. Engrs., 31 (3), 269 (2000).
13. Liu, J., H. Lee, M. Huesca, A. Young, and C. Allen, "Liposome Formulation of a Novel Hydrophobic Aryl-Imidazole Compound for Anti-Cancer Therapy," Cancer Chemother. Pharmacol., 58 (3), 306 (2006).
14. Lusis, A. J., "Atherosclerosis," Nature, 407 (6801), 233 (2000).
15. Rogers, C., S. Parikh, P. Seifert, and E. R. Edelman, "Endogenous Cell Seeding: Remnant Endothelium after Stenting Enhances Vascular Repair," Circulation, 94 (11), 2909 (1996).
16. Schwartz, C. J., A. J. Valente, and E. A. Sprague, "A Modern View of Atherogeriesis," Am. J. Cardiol., 71 (6), 9B (1993).
17. Serruys, P. W., D. P. Foley, R. L. Kirkeeide and S. B. King, 3rd, "Restenosis Revisited: Insights Provided by Quantitative Coronary Angiography," Am. Heart. J., 126(5), 1243 (1993).
18. 2+-induced Cell Death is Mediated by the Induction of Intracellular ROS in ARPE-19 Cells," Curr. Eye Res., 28 (3),195 (2004).
19. Walsh, K. and J. M. Isner, "Apoptosis in Inflammatory-Fibroproliferative Disorders of the Vessel Wall," Cardiovase. Res., 45 (3), 756 (2000).
20. Wu, S. N., C. C. Chen, H. F. Li, Y. K. Lo, S. A. Chen, and H. T. Chiang, "Stimulation of the BK(Ca) Channel in Cultured Smooth Muscle Cells of Human Trachea by Magnolol," Thorax, 57 (1), 67 (2002).
21. Wu, P. C., W. S. Wang, Y. T. Huang, H. S. Shen, Y. W. Lo, T. L. Tsai, D. B. Shieh, and C. S. Yeh, "Porous Iron Oxide Based Nanorods Developed as Delivery Nanocapsules," Chemistry, 13 (14), 3878 (2007).